Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA.

Nature. 2007 Oct 4;449(7162):557-63.

PMID:
17914389
2.

Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.

Houghton J, Li H, Fan X, Liu Y, Liu JH, Rao VP, Poutahidis T, Taylor CL, Jackson EA, Hewes C, Lyle S, Cerny A, Bowen G, Cerny J, Moore N, Kurt-Jones EA, Erdman SE.

Stem Cells Dev. 2010 Aug;19(8):1153-66. doi: 10.1089/scd.2009.0439.

3.

Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

Swamydas M, Ricci K, Rego SL, Dréau D.

Cell Adh Migr. 2013 May-Jun;7(3):315-24. doi: 10.4161/cam.25138.

4.

Tissue-resident stem cells promote breast cancer growth and metastasis.

Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU.

Carcinogenesis. 2009 Apr;30(4):589-97. doi: 10.1093/carcin/bgp036.

PMID:
19181699
5.

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.

Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, Li C, Chong M, Ibrahim T, Mercatali L, Amadori D, Lu X, Xie D, Li QJ, Wang XF.

Nat Cell Biol. 2013 Mar;15(3):284-94. doi: 10.1038/ncb2690.

6.

Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis.

Goldstein RH, Reagan MR, Anderson K, Kaplan DL, Rosenblatt M.

Cancer Res. 2010 Dec 15;70(24):10044-50. doi: 10.1158/0008-5472.CAN-10-1254.

7.

Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis.

Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC.

Carcinogenesis. 2011 Apr;32(4):477-87. doi: 10.1093/carcin/bgr009.

8.

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA.

Cell. 2005 May 6;121(3):335-48.

9.

The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.

Xu K, Tian X, Oh SY, Movassaghi M, Naber SP, Kuperwasser C, Buchsbaum RJ.

Breast Cancer Res. 2016 Jan 28;18(1):14. doi: 10.1186/s13058-016-0674-8.

10.

[A new model of metastatic dissemination of breast cancer bringing into play mesenchymal stem cells].

Darbon JM.

Bull Cancer. 2007 Dec;94(12):1035-6. French. No abstract available.

11.

Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.

Chaturvedi P, Gilkes DM, Wong CC; Kshitiz., Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL.

J Clin Invest. 2013 Jan;123(1):189-205. doi: 10.1172/JCI64993. Erratum in: J Clin Invest. 2013 Mar 1;123(3):1402.

12.

Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.

Chaturvedi P, Gilkes DM, Takano N, Semenza GL.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2120-9. doi: 10.1073/pnas.1406655111.

13.

Human Adipose-Derived Mesenchymal Stromal Cells May Promote Breast Cancer Progression and Metastatic Spread.

Kamat P, Schweizer R, Kaenel P, Salemi S, Calcagni M, Giovanoli P, Gorantla VS, Eberli D, Andres AC, Plock JA.

Plast Reconstr Surg. 2015 Jul;136(1):76-84. doi: 10.1097/PRS.0000000000001321.

PMID:
26111315
14.

Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.

Khalid A, Wolfram J, Ferrari I, Mu C, Mai J, Yang Z, Zhao Y, Ferrari M, Ma X, Shen H.

Mini Rev Med Chem. 2015;15(13):1063-72. Review.

15.
16.

Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.

Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.

J Nucl Med. 2015 Apr;56(4):600-6. doi: 10.2967/jnumed.114.146662.

17.

Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion.

Salo S, Bitu C, Merkku K, Nyberg P, Bello IO, Vuoristo J, Sutinen M, Vähänikkilä H, Costea DE, Kauppila JH, Lehenkari P, Dayan D, Vered M, Risteli J, Salo T.

PLoS One. 2013 Oct 21;8(10):e77692. doi: 10.1371/journal.pone.0077692. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/2bacf09d-7bb8-43ac-a098-b3b9e486d854. Kauppila, Joonas [corrected to Kauppila, Joonas H].

18.

Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.

Shen K, Luk S, Hicks DF, Elman JS, Bohr S, Iwamoto Y, Murray R, Pena K, Wang F, Seker E, Weissleder R, Yarmush ML, Toner M, Sgroi D, Parekkadan B.

Nat Commun. 2014 Dec 9;5:5662. doi: 10.1038/ncomms6662.

19.

Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity.

Rappa G, Mercapide J, Lorico A.

Am J Pathol. 2012 Jun;180(6):2504-15. doi: 10.1016/j.ajpath.2012.02.020.

20.

Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.

Soon PS, Kim E, Pon CK, Gill AJ, Moore K, Spillane AJ, Benn DE, Baxter RC.

Endocr Relat Cancer. 2013 Jan 7;20(1):1-12. doi: 10.1530/ERC-12-0227.

Items per page

Supplemental Content

Support Center